Related references
Note: Only part of the references are listed.A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin
Naris Nilubol et al.
CLINICAL ENDOCRINOLOGY (2017)
PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas
Zahra Nozhat et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
MicroRNAs in the thyroid
Myriem Boufraqech et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Non-Coding RNAs in Thyroid Cancer
Ranran Zhang et al.
ENDOCRINE PATHOLOGY (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Signaling pathways in medullary thyroid carcinoma: therapeutic implications
Zahra Nozhat et al.
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY (2016)
RET Proto Oncogene Mutation Detection and Medullary Thyroid Carcinoma Prevention
Marjan Zarif Yeganeh et al.
Asian Pacific Journal of Cancer Prevention (2015)
MicroRNA-618 modulates cell growth via targeting PI3K/Akt pathway in human thyroid carcinomas
L. Yi et al.
INDIAN JOURNAL OF CANCER (2015)
Personalized Therapy in Patients With Anaplastic Thyroid Cancer: Targeting Genetic and Epigenetic Alterations
Neal Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
miR-142-3p Down-Regulation Contributes to Thyroid Follicular Tumorigenesis by Targeting ASH1L and MLL1
Marianna Colamaio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
BRAFV600E Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review
Ahmet Sahpaz et al.
BALKAN MEDICAL JOURNAL (2015)
MicroRNA-618 modulates cell growth via targeting PI3K/Akt pathway in human thyroid carcinomas
L. Yi et al.
INDIAN JOURNAL OF CANCER (2015)
Thyroid cancer mortality and incidence: A global overview
Carlo La Vecchia et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line
Qianpeng Cheng et al.
ANNALES D ENDOCRINOLOGIE (2014)
Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin
Y. Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Continued Rapid Increase in Thyroid Cancer Incidence in California: Trends by Patient, Tumor, and Neighborhood Characteristics
Pamela L. Horn-Ross et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Analysis of BRAFV600E mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies
Bingfei Zhang et al.
DIAGNOSTIC PATHOLOGY (2014)
Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer
Zongjing Zhang et al.
ENDOCRINE-RELATED CANCER (2014)
miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3
Myriem Boufraqech et al.
ENDOCRINE-RELATED CANCER (2014)
MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET
Lijun Duan et al.
FEBS LETTERS (2014)
MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development
Xiaoping Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival
Veronika Mancikova et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Genome-Wide Methylation Patterns in Papillary Thyroid Cancer Are Distinct Based on Histological Subtype and Tumor Genotype
Ryan J. Ellis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights
Matthias S. Dettmer et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas
Bartosz Wojtas et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours
Marialuisa Sponziello et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Deregulation of microRNA expression in thyroid neoplasias
Pierlorenzo Pallante et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
Yin Xiong et al.
PLOS ONE (2014)
ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
Meenu Jain et al.
PLOS ONE (2014)
Methylation of DACT2 Promotes Papillary Thyroid Cancer Metastasis by Activating Wnt Signaling
Zhiyan Zhao et al.
PLOS ONE (2014)
Concomitant RAS, RET/PTC, or BRAF Mutations in Advanced Stage of Papillary Thyroid Carcinoma
Minjing Zou et al.
THYROID (2014)
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
Cesar Seigi Fuziwara et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma
De-tao Yin et al.
ENDOCRINE-RELATED CANCER (2013)
Reactivation of the Silenced Thyroid Hormone Receptor β Gene Expression Delays Thyroid Tumor Progression
Won Gu Kim et al.
ENDOCRINOLOGY (2013)
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
Jena Hudson et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma
Tomoo Jikuzono et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
DNA Methylation Signatures Identify Biologically Distinct Thyroid Cancer Subtypes
Sandra Rodriguez-Rodero et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid Cancer
Dingxie Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Molecular mechanisms of antiseizure drug activity at GABAA receptors
L. John Greenfield
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancy
Simona Keller et al.
ONCOLOGY LETTERS (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo
Maria Graziella Catalano et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Approach to the Patient with Anaplastic Thyroid Carcinoma
Robert C. Smallridge
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2
Francesco Esposito et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome
Caterina Mian et al.
THYROID (2012)
Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer
Maria Graziella Catalano et al.
Frontiers in Endocrinology (2012)
MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma
Linwah Yip et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Levels of histone acetylation in thyroid tumors
Cinzia Puppin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells
Peng Hou et al.
ENDOCRINE-RELATED CANCER (2011)
Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells
Xiaoyun Dong et al.
ENDOCRINE-RELATED CANCER (2011)
MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells
Patrick Brest et al.
ENDOCRINE-RELATED CANCER (2011)
Mitogen-Inducible Gene-6 Is a Multifunctional Adaptor Protein with Tumor Suppressor-Like Activity in Papillary Thyroid Cancer
Chi-Iou Lin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Enhancer of Zeste Homolog 2 Overexpression Has a Role in the Development of Anaplastic Thyroid Carcinomas
Eleonora Borbone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Molecular Analysis of the RET Proto-Oncogene Key Exons in Patients with Medullary Thyroid Carcinoma: A Comprehensive Study of the Iranian Population
Ehsan Alvandi et al.
THYROID (2011)
Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma
Mehdi Hedayati et al.
JOURNAL OF THYROID RESEARCH (2011)
Leptin: A Correlated Peptide to Papillary Thyroid Carcinoma?
Mehdi Hedayati et al.
JOURNAL OF THYROID RESEARCH (2011)
Targeted therapy of thyroid cancer
Steven I. Sherman
BIOCHEMICAL PHARMACOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Downregulation of Rap1GAP through Epigenetic Silencing and Loss of Heterozygosity Promotes Invasion and Progression of Thyroid Tumors
Hui Zuo et al.
CANCER RESEARCH (2010)
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Jiahuai Tan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression
Sofia Asioli et al.
MODERN PATHOLOGY (2010)
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
E. Borbone et al.
ONCOGENE (2010)
Targeting DNA methylation for epigenetic therapy
Xiaojing Yang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
David B. Seligson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
International patterns and trends in thyroid cancer incidence, 1973-2002
Briseis A. Kilfoy et al.
CANCER CAUSES & CONTROL (2009)
Chromobox Protein Homologue 7 Protein, with Decreased Expression in Human Carcinomas, Positively Regulates E-Cadherin Expression by Interacting with the Histone Deacetylase 2 Protein
Antonella Federico et al.
CANCER RESEARCH (2009)
Analysis of Deregulated miRNAs is Helpful to Distinguish Poorly Differentiated Thyroid Carcinoma from Papillary Thyroid Carcinoma
S. Schwertheim et al.
HORMONE AND METABOLIC RESEARCH (2009)
Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma
Jennifer A. Woyach et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Histone Deacetylase Inhibitors in Cancer Therapy
Andrew A. Lane et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas
Tetsuo Kondo et al.
LABORATORY INVESTIGATION (2009)
New targets and therapeutic approaches for endocrine malignancies
Martin Fassnacht et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Richard T. Kloos et al.
THYROID (2009)
Association of PTEN Gene Methylation With Genetic Alterations in the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Thyroid Tumors
Peng Hou et al.
CANCER (2008)
Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer
Pierlorenzo Pallante et al.
CANCER RESEARCH (2008)
Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
Alfonso Duenas-Gonzalez et al.
CANCER TREATMENT REVIEWS (2008)
MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility
Marina N. Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers
Zhi Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
In Vivo Imaging of Functional Targeting of miR-221 in Papillary Thyroid Carcinoma
Hyun Joo Kim et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
Preetha Anand et al.
PHARMACEUTICAL RESEARCH (2008)
Lack of mutations in the thyroid hormone receptor (TR) α and β genes but frequent hypermethylation of the TRβ gene in differentiated thyroid tumors
Biju Joseph et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Methylation status of genes in papillary thyroid carcinoma
Jason A. Smith et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2007)
The RASSF1A tumor suppressor
Howard Donninger et al.
JOURNAL OF CELL SCIENCE (2007)
Prognosis and prognostic factors of follicular carcinoma in Japan: Importance of postoperative pathological examination
Yasuhiro Ito et al.
WORLD JOURNAL OF SURGERY (2007)
Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model
Susanne Cahill et al.
MOLECULAR CANCER (2007)
Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer
Peng Hou et al.
CLINICAL CANCER RESEARCH (2007)
High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/Akt pathway in thyroid tumors
Yangang Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
DNA hypermethylation status of multiple genes in papillary thyroid carcinomas
Eiwa Ishida et al.
PATHOBIOLOGY (2007)
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27(Kip1) protein levels and cell cycle
Rosa Visone et al.
ENDOCRINE-RELATED CANCER (2007)
Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model
Susanne Cahill et al.
MOLECULAR CANCER (2006)
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer
Shuiying Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma
Frank Weber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma
Undraga Schagdarsurengin et al.
THYROID (2006)
MicroRNA deregulation in human thyroid papillary carcinomas
P. Pallante et al.
ENDOCRINE-RELATED CANCER (2006)
PTEN promoter methylation in sporadic thyroid carcinomas
F Alvarez-Nunez et al.
THYROID (2006)
The role of microRNA genes in papillary thyroid carcinoma
HL He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Global histone modification patterns predict risk of prostate cancer recurrence
DB Seligson et al.
NATURE (2005)
Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers
S Ogasawara et al.
ONCOGENE (2004)
RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors:: Evidence for distinct molecular pathways in thyroid follicular carcinoma
MN Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Hypermethylation of the CDKN2/pl6(INK4A) promotor in thyroid carcinogenesis
C Boltze et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
Genome-wide appraisal of thyroid cancer progression
VB Wreesmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Share Paper
